Navigation Links
Ansell Launches Worlds's First Antimicrobial Surgical Glove
Date:5/4/2010

MELBOURNE, May 4, 2010 /PRNewswire/ -- Ansell today announced the launch of their new GAMMEX(R) Powder-Free glove with AMT Antimicrobial Technology, at the Annual Congress of the Royal Australasian College of Surgeons in Perth, Australia.

It is the first surgical glove which incorporates a proprietary antimicrobial coating to provide an additional level of protection to surgical staff against viruses and bacteria, in the event of a breach during surgery.

The last decade has witnessed a rapid expansion of the medical gloves market globally. Major drivers for this growth are improving healthcare systems around the world and the increasing awareness by healthcare workers that gloves offer an effective protective barrier against contamination from bacteria and viruses. Ansell's new AMT Antimicrobial Technology reduces surgical staff risks of exposure to blood-borne pathogens through a higher level of protection.

Extensive in vitro laboratory testing showed that the antimicrobial coating killed >99 per cent of Hepatitis C1 and 99 percent of HIV-1 (strain Mn) within 60 seconds of exposure through a simulated glove breach.

GAMMEX(R) Powder-Free glove with AMT Antimicrobial Technology also kills between 99.7% to >99.999% of 8 common healthcare infectious bacteria, comprising gram-positive, gram-negative, and drug-resistant bacteria (e.g. MRSA, VRE) within 60 seconds from exposure.

"Ansell's proprietary AMT Antimicrobial surgical glove technology is the result of intensive and collaborative research, and demonstrates the Company's ability for industry leading innovation and new product development", says Magnus Nicolin, CEO of Ansell Ltd.

"It also underscores Ansell's commitment to continuously invest in seeking optimal solutions to better protect healthcare professionals in a world with an increasing number of high risk pathogens", he continues.

GAMMEX(R) Powder-Free glove with AMT Antimicrobial Technology features a unique and proprietary inner coating, containing skin friendly agents and chlorhexidine gluconate (CHG), an effective antimicrobial agent commonly found in products such as antiseptics and mouthwash.

Ansell's AMT Antimicrobial Technology is a world first and is now being launched in Australia. It will be progressively rolled out in all Ansell markets

1, Tested versus Bovine Viral Diarrhea Virus (BVDV), a common surrogate for Hepatitis C.

About Ansell

Ansell is a world leader in providing superior health and safety protection solutions that enhance human well being. With operations in the Americas, Europe and Asia Pacific, Ansell employs more than 10,000 people worldwide and holds leading market positions in industrial and medical gloves. Ansell is also a leading player in the household gloves and condom market segment globally. Information on Ansell and its products can be found at http://www.ansell.com.


'/>"/>
SOURCE Ansell Healthcare
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Managing Risk Through Quality: Ansell Healthcares Innovative Gammex(R) Glove Range on Display at Arab Health 2009
2. Ansell Healthcare Espresses Firm Commitment to Support Continued Education of Healthcare Professionals Worldwide
3. Research Triangle Area Health Care Collaborative Launches Bridges to Excellence(R) Initiative to Improve Quality and Lower Costs
4. Novozymes Launches Enzyme to Reduce Acrylamide in Food
5. Enova Medical Launches Exos Corporation
6. Elekta Launches New Linear Accelerator at 2007 ESTRO to Expand Cancer Treatment Availability
7. Signalifes Dr. Harmison Launches Award-Winning Ambulatory Heart Monitor
8. ThirdBiotech Networking Group Launches
9. BioReliance Launches Next-Generation Genotoxicity Screening Service
10. Midwest Research Institute Launches Center for Biological Safety and Security (CBS2)
11. BioReliance Corporation Launches iNet(TM) for Online Results Tracking of Biological Safety Tests
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016   Boston Biomedical ... novel compounds designed to target cancer stemness pathways, ... been granted Orphan Drug Designation from the U.S. ... of gastric cancer, including gastroesophageal junction (GEJ) cancer. ... designed to inhibit cancer stemness pathways by targeting ...
(Date:6/23/2016)... Lawrence, MA (PRWEB) , ... June 23, 2016 ... ... the Peel Plate® YM (Yeast and Mold) microbial test has received AOAC Research ... test platform of microbial tests introduced last year,” stated Bob Salter, Vice President ...
(Date:6/23/2016)... ... , ... Supplyframe, the Industry Network for electronics hardware design ... Located in Pasadena, Calif., the Design Lab’s mission is to bring together inventors ... and brought to market. , The Design Lab is Supplyframe’s physical representation of ...
(Date:6/23/2016)... , June 23, 2016  Blueprint Bio, a ... discoveries to the medical community, has closed its Series ... Matthew Nunez . "We have received a ... the capital we need to meet our current goals," ... provide us the runway to complete validation on the ...
Breaking Biology Technology:
(Date:4/19/2016)... DUBAI , UAE, April 20, 2016 ... can be implemented as a compact web-based "all-in-one" system ... in the biometric fingerprint reader or the door interface ... requirements of modern access control systems. The minimal dimensions ... the ID readers into the building installations offer considerable ...
(Date:4/14/2016)... 2016 BioCatch ™, the ... announced the appointment of Eyal Goldwerger as ... Goldwerger,s leadership appointment comes at a time of ... deployment of its platform at several of the world,s ... discerns unique cognitive and physiological factors, is a winner ...
(Date:3/31/2016)... PROVIDENCE, R.I. , March 31, 2016  Genomics ... leadership of founding CEO, Barrett Bready , M.D., ... addition, members of the original technical leadership team, including ... Vice President of Product Development, Steve Nurnberg and Vice ... have returned to the company. Dr. Bready ...
Breaking Biology News(10 mins):